Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

243.78 USD +2.03 (+0.84%)
Official Closing Price Updated: 4:34 PM EST, Nov 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Sage Therapeutics Dives On $1.5 Billion Collaboration Deal With Biogen
Biotech company Sage Therapeutics inked a $1.5 billion deal to develop two key drugs in depression treatment and movement disorders with Biogen. But Sage stock collapsed Friday on the news. 
From Investor's Business Daily
Sage Therapeutics Dives On $1.5 Billion Collaboration Deal With Biogen
Biotech company Sage Therapeutics inked a $1.5 billion deal to develop two key drugs in depression treatment and movement disorders with Biogen. But Sage stock collapsed Friday on the news. 
From Investor's Business Daily
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone... 
From Business Wire News Releases
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
From GlobeNewswire News Releases
Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Biogen Inc. – BIIB
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
From GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors 
From Business Wire News Releases
LABU, BIIB, BTAI, BLUE: Large Outflows Detected at ETF
Symbols mentioned in this story: LABU, BIIB, BTAI, BLUE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
BIIB INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc.
From GlobeNewswire News Releases
TalkMarkets Tuesday Talk: Optimism Advancing On Turkeys
Boosted by the the AstraZeneca vaccine news US markets closed higher on Monday. Encouraged by the GSA release of Presidential transition funds post-close, Tuesday market futures are trading higher. 
Tags Pharma/Biotech Stocks / Equities Commodities
From Blogs - TalkMarkets
Large Cap Biopharma Performance and Metrics Q3 2020; ETFs Are Winners
Surging coronavirus infections has even nicked the healthcare sector down 3% for the week. 
Tags ETFs Healthcare Stocks / Equities
From Blogs - TalkMarkets
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Biogen, Inc. (“Biogen” or the “Company”)... 
From Business Wire News Releases
BIIB Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Biogen Inc. Investors of Class Action and Encourages Investors to Contact the Firm
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain of its officers, on behalf of... 
From Business Wire News Releases
5 Value Stocks To Watch In The Healthcare Sector
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that ... 
Tags Dividends General BIO
From Benzinga
ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment
- Developing STING Antagonist for Treatment of Severe Lupus 
From PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Reminds Biogen Inc. Investors of Important January 12 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of
From GlobeNewswire News Releases
3 Best Pharma Stocks to Buy Right Now
These three stocks are ready to break out. 
Tags PFE BNTX BIIB
From Motley Fool
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
From GlobeNewswire News Releases
BIIB INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Biogen Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of... 
From PR Newswire
Analysts Expect SYV Will Reach $72
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Biogen Inc. Investors of Important January 12 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Exc
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Biogen Inc. (NASDAQ: BIIB), between October 22, 2019 and November 6, 2020, inclusive (the "Class Period") of... 
From PR Newswire
The Law Offices of Frank R. Cruz Announces Investigation of Biogen, Inc. (BIIB) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Biogen, Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) on behalf of investors concerning the Company’s possible violations of federal... 
From Business Wire News Releases
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Biogen, Inc. (BIIB) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Biogen, Inc. (BIIB) on Behalf of Investors 
From Business Wire News Releases
BIIB Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen Inc. Investors of Class Action and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. – BIIB
From GlobeNewswire News Releases
2 Bargain Stocks You Can Buy Right Now
They're dirt cheap compared to their peers. 
Tags FB Market News XLV
From Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intercept Pharmaceuticals, Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Biogen, Inc. (BIIB) on Behalf of Investors
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Biogen, Inc. (BIIB) on Behalf of Investors 
From Business Wire News Releases
Notable Wednesday Option Activity: AAN, BIIB, VRNT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Aarons Holdings Co Inc (AAN), where a total volume of 2,312 contracts has been... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.